Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
243.6 USD | +2.59% | +8.17% | +19.75% |
04-19 | RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target | MT |
04-18 | Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.75% | 7.38B | C | ||
+13.16% | 129B | A- | ||
-9.17% | 10.77B | A- | ||
+3.60% | 9.05B | C | ||
+22.28% | 4.88B | B+ | ||
+7.55% | 3.41B | C- | ||
-0.21% | 3.07B | B- | ||
-4.80% | 2.24B | - | - | |
-4.72% | 2.12B | - | ||
-22.91% | 1.79B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INSP Stock
- Ratings Inspire Medical Systems, Inc.